US 12227581
Anti-BCMA single domain antibodies and application thereof
granted A61KA61K40/11A61K40/31
Quick answer
US patent 12227581 (Anti-BCMA single domain antibodies and application thereof) held by SHENZHEN PREGENE BIOPHARMA CO., LTD. expires Mon Feb 13 2045 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- SHENZHEN PREGENE BIOPHARMA CO., LTD.
- Grant date
- Tue Feb 18 2025 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Feb 13 2045 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 11
- CPC classes
- A61K, A61K40/11, A61K40/31, A61K40/4215, A61K48/005